1 “...The potential cost savings of switching to biosimilars without compromising on clinical...”

2 “...The potential cost savings of switching to biosimilars without compromising on clinical...”

3 “...The availability of biosimilar infliximab (INX) has been postulated to offer cost savings compared...”

4 “...The availability of biosimilar infliximab (INX) has been postulated to offer cost savings compared...”

5 “.... The introduction and appropriate use of junctional tourniquets has the potential to save many lives. A review...”

6 “.... The introduction and appropriate use of junctional tourniquets has the potential to save many lives. A review...”

7 “... effectiveness and potential cost savings that home dialysis therapies may yield, it is often argued...”

8 “... of apomorphine hydrochloride subcutaneous (APO SC), representing savings of $3,695 per patient over 5 years. Some...”

9 “...) + tiotropium (TIO; cost savings = $6,674, incremental quality-adjusted life-years [QALYs] = 0.0085). CADTH...”

10

11

12

13

14

15

16

17